☰

Zhican Qu - Publications

Affiliations: 
The University of Alabama, Tuscaloosa, AL 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Zamani A, Qu Z. Serotonin activates angiogenic phosphorylation signaling in human endothelial cells. Febs Letters. 586: 2360-5. PMID 22683950 DOI: 10.1016/J.Febslet.2012.05.047  0.399
2012 Zhai L, Zamani A, Liu X, Wang Y, Maxuitenko Y, Alvarez R, Estes J, Li R, Qu Z. Abstract 3727: Targeting autotaxin to reduce chemotherapy resistance in ovarian cancer Cancer Research. 72: 3727-3727. DOI: 10.1158/1538-7445.Am2012-3727  0.302
2012 Zamani A, Roy A, Zhai L, Maxuitenko Y, Li R, Qu Z. Abstract 2333: Serotonin: A known neurotransmitter functions as an angiokine to support cancer progression Cancer Research. 72: 2333-2333. DOI: 10.1158/1538-7445.Am2012-2333  0.388
2011 Lin C, Lu W, Zhai L, Bethea T, Berry K, Qu Z, Waud WR, Li Y. Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo. Febs Letters. 585: 3120-5. PMID 21907199 DOI: 10.1016/j.febslet.2011.08.046  0.347
2011 Zamani A, Zhai L, Roy AM, Li R, Qu Z, Maxuitenko YY. Abstract 5154: Serotonin signaling as a novel target of tumor angiogenesis Cancer Research. 71: 5154-5154. DOI: 10.1158/1538-7445.Am2011-5154  0.37
2011 Zhai L, Roy AM, Zamani A, Liu X, Wang Y, Li R, Qu Z. Abstract 4265: Bithionol as an inhibitor of tumor angiogenesis Cancer Research. 71: 4265-4265. DOI: 10.1158/1538-7445.Am2011-4265  0.363
2011 Zamani A, Zhai L, Berry KL, Roberts M, Stackhouse M, Li R, Maxuitenko YY, Qu Z. Abstract 3114: Effects of tumor-stromal interactions on gene expression in panel of mouse tumor models Cancer Research. 71: 3114-3114. DOI: 10.1158/1538-7445.Am2011-3114  0.316
2010 Qu Z, Roy AM, Maxuitenko YY, Li R, Huang ZQ, Johnson MR. Abstract 563: Novel role of VEGF and neuropilin-1 in breast cancer tumor-stromal interactions Cancer Research. 70: 563-563. DOI: 10.1158/1538-7445.Am10-563  0.341
2010 Roy AM, Zhai L, Wennerberg K, Waud WR, Gormon GS, Coward L, Li R, Ananthan S, Qu Z. Abstract 5474: Targeting endothelial tubulogenesis for anticancer therapeutic development Cancer Research. 70: 5474-5474. DOI: 10.1158/1538-7445.Am10-5474  0.309
2010 Zamani A, Roy A, Zhai L, Li R, Qu Z. Abstract 2390: Serotonin signal transduction in human endothelial cells Cancer Research. 70: 2390-2390. DOI: 10.1158/1538-7445.Am10-2390  0.401
2010 Zhai L, Li R, Qu Z. Abstract 1562: PYK2 and FAK in breast cancer Cancer Research. 70: 1562-1562. DOI: 10.1158/1538-7445.Am10-1562  0.404
2009 Westbrook L, Ramanathan HN, Isayeva T, Mittal AR, Qu Z, Johnson MD, Kern FG, Ponnazhagan S, Grubbs CJ, Thottassery JV. High Cks1 expression in transgenic and carcinogen-initiated mammary tumors is not always accompanied by reduction in p27Kip1. International Journal of Oncology. 34: 1425-31. PMID 19360356 DOI: 10.3892/Ijo_00000271  0.342
2007 Ranganathan S, Wang Y, Kern FG, Qu Z, Li R. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta. Proteins. 67: 709-19. PMID 17335005 DOI: 10.1002/Prot.21348  0.51
2006 Roy AM, Tiwari KN, Parker WB, Secrist JA, Li R, Qu Z. Antiangiogenic activity of 4'-thio-beta-D-arabinofuranosylcytosine. Molecular Cancer Therapeutics. 5: 2218-24. PMID 16985055 DOI: 10.1158/1535-7163.MCT-06-0048  0.342
2006 Manuvakhova M, Thottassery JV, Hays S, Qu Z, Rentz SS, Westbrook L, Kern FG. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells. Oncogene. 25: 6003-14. PMID 16682955 DOI: 10.1038/Sj.Onc.1209592  0.513
2004 Thottassery JV, Sun Y, Westbrook L, Rentz SS, Manuvakhova M, Qu Z, Samuel S, Upshaw R, Cunningham A, Kern FG. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors. Cancer Research. 64: 4637-47. PMID 15231676 DOI: 10.1158/0008-5472.Can-03-2645  0.48
1998 Qu Z, Wolfraim LA, Svaren J, Ehrengruber MU, Davidson N, Milbrandt J. The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells Journal of Cell Biology. 142: 1075-1082. PMID 9722618 DOI: 10.1083/Jcb.142.4.1075  0.323
1996 Qu Z, Apel ED, Doherty CA, Hoffman PW, Merlie JP, Huganir RL. The synapse-associated protein rapsyn regulates tyrosine phosphorylation of proteins colocalized at nicotinic acetylcholine receptor clusters. Molecular and Cellular Neurosciences. 8: 171-84. PMID 8918833 DOI: 10.1006/mcne.1996.0055  0.613
1995 Swope SL, Qu Z, Huganir RL. Phosphorylation of the nicotinic acetylcholine receptor by protein tyrosine kinases. Annals of the New York Academy of Sciences. 757: 197-214. PMID 7541972 DOI: 10.1111/j.1749-6632.1995.tb17476.x  0.615
1994 Qu Z, Huganir RL. Comparison of innervation and agrin-induced tyrosine phosphorylation of the nicotinic acetylcholine receptor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 6834-41. PMID 7965081 DOI: 10.1523/Jneurosci.14-11-06834.1994  0.597
1990 Qu ZC, Moritz E, Huganir RL. Regulation of tyrosine phosphorylation of the nicotinic acetylcholine receptor at the rat neuromuscular junction. Neuron. 4: 367-78. PMID 1690564 DOI: 10.1016/0896-6273(90)90049-L  0.578
Show low-probability matches.